Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) targeting central nervous system disorders. Its structure supports the creation of bioactive molecules due to the presence of the piperazine ring and cyclobutyl group, which can enhance binding affinity and selectivity in drug-receptor interactions. Commonly employed in medicinal chemistry for constructing novel analogs in drug discovery programs. Also utilized in the preparation of kinase inhibitors and receptor modulators in research settings.